Long-Term Clinical Outcomes of the Drug-Eluting Stents in the Real World (DESIRE) Registry
β Scribed by AMANDA SOUSA; J. RIBAMAR COSTA; Jr; ADRIANA C. MOREIRA; MANUEL CANO; GALO MALDONADO; RICARDO A. COSTA; RICARDO PAVANELLO; EDSON R. ROMANO; CANTIDIO CAMPOS; NAGIB HADDAD; ALEXANDRE ABIZAID; FAUSTO FERES; LUIZ ALBERTO MATTOS; RODOLFO STAICO; J. EDUARDO SOUSA
- Book ID
- 109216830
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 149 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0896-4327
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Objectives: We sought to evaluate the safety and performance of the Janus TacrolimusβEluting stent (TES) in an unselected population of patients, without application of restrictive clinical or angiographic criteria. ## Background: Continued attention to the safety, efficacy, and d
## Abstract Objective: To evaluate the longβterm clinical outcomes of patients undergoing percutaneous coronary intervention for saphenous vein graft (SVG) disease. Specifically, we compared clinical endpoints of patients who received sirolimusβeluting stents (SES) versus bareβmetal stents (BMS) fo